Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Molecular Sciences|May 27, 2023
Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA BiomarkersStefania Bellone, Blair McNamara, Levent Mutlu, et al.
American Journal of Obstetrics and Gynecology|July 30, 2013
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2)Diana P English, Stefania Bellone, Emiliano Cocco, et al.
Gynecologic Oncology|August 31, 2014
Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivoSalvatore Lopez, Carlton L Schwab, Emiliano Cocco, et al.
Gynecologic Oncology|October 15, 2025
Immunohistochemistry, next generation sequencing (NGS), and whole exome sequencing concordance in HER2 testing in uterine serous carcinoma: a retrospective analysisVictoria M Ettorre, Stefania Bellone, Natalia Buza, et al.
Cancer|January 20, 2011
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibodyJoyce Varughese, Emiliano Cocco, Stefania Bellone, et al.
Gynecologic Oncology|January 3, 2012
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expressionLuisa Carrara, Federica Guzzo, Dana M Roque, et al.
Cancer Research|May 19, 2005
Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxinAlessandro D Santin, Stefania Cané, Stefania Bellone, et al.
The Journal of Clinical Investigation|October 11, 2016
Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancerMingzhu Yin, Xia Li, Shu Tan, et al.
Gynecologic Oncology|September 10, 2013
HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitorDiana P English, Dana M Roque, Luisa Carrara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomasAlessandro D Santin, Stefania Bellone, Eric R Siegel, et al.
Pageof 17